Opsona Therapeutics
Latest round
- Series C
Last raised
- Oct 2013
Total raised
- $92M
Investors
- 13
About Opsona Therapeutics
Opsona Therapeutics is a biotechnology company focused on novel therapeutic and preventative approaches to autoimmune and inflammatory diseases.
Who invested in Opsona Therapeutics
13 investors across 7 rounds
See all investors in Opsona Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Oct 2, 2013
Amount
$4.1M
Investors
Series C
Oct 2, 2013
Amount
$4.1M
Investors
Series C
Apr 29, 2013
Amount
$43M
Investors
Series B
Jun 15, 2009
Amount
$4.6M
Investors
Series B
May 19, 2009
Amount
$4.5M
Investors
Series B
Feb 18, 2009
Amount
$23M
Investors
Series A
Feb 24, 2005
Amount
$8.6M
Investors
Questions about Opsona Therapeutics
Who invested in Opsona Therapeutics?
Opsona Therapeutics has 13 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Opsona Therapeutics raised?
Opsona Therapeutics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Opsona Therapeutics last raise money?
Opsona Therapeutics's most recent round on record is a Series C, in Oct 2013.
What does Opsona Therapeutics do?
Opsona Therapeutics is a biotechnology company focused on novel therapeutic and preventative approaches to autoimmune and inflammatory diseases.
Where is Opsona Therapeutics headquartered?
Opsona Therapeutics is headquartered in Dublin, Ireland.
Which VCs invest in companies like Opsona Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Opsona Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Opsona Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.